- 2020 (22) ▼
- 2019 (41) ▼
- 2018 (21) ▼
- 2017 (10) ▼
Sharing some good news with our Gaucher community...
Takeda’s Medical Expert Committee (MEC) have recently approved 17 Gaucher patients from Pakistan, Sudan, Tanzania and Tunisia on to their annual LSD Charitable Access Programme (CAP).
In addition, working in partnership with the IGA, Pfizer have also agreed to provide Charitable Access for a patient from Pakistan and Sanofi Genzyme have approved treatment for an 11-year old boy from Kenya as part of their ongoing commitment